Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.
Related Posts
Ontario premier allows early alcohol sales for US-Canada gold medal game
Bars and restaurants across Ontario will be allowed to start serving alcohol early on Sunday in anticipation of the gold medal men’s ho...
People still want to see BTS and Harry Styles concerts, lifting Live Nation’s sales
Ticketmaster parent Live Nation Entertainment on Thursday reported fourth-quarter sales that topped Wall Street’s expectations, helped ...
Wayfair’s stock sinks, as investors worry expansion plans will hurt profits
Wayfair’s stock suffered its worst postearnings reaction in nearly four years, after the company unexpectedly swung to a net loss for t...
Deere’s stock is having its best month in 50 years, as the tractor maker rides the AI boom
Deere’s stock surged further into record territory Thursday after a big earnings beat and a bullish outlook for full-year sales growth....
Will Microsoft’s stock finally rebound? A board member just bet $2 million on a turnaround.
There have been a few instances of insider purchases in the wake of the recent software selloff, with the latest coming from Microsoft ...
Figma’s stock soars as AI earnings momentum helps ease investors’ doubts
Figma’s revenue grew 40% in the fourth quarter as net dollar retention rate increased to 136%
Palo Alto Networks’ stock slides as underwhelming outlook overshadows AI messaging
The cybersecurity company says it’s poised to benefit as AI creates “new classes of risks.”
Norwegian Cruise Line stock is rising. A big activist reportedly has taken a stake.
Norwegian Cruise Line shares rose on Tuesday after a report an activist investor has taken a stake and plans to shake up the struggling...
U.S. stock futures inch higher as investors digest ongoing tech selloff
U.S. stock futures were little changed late Monday, following another brutal week for tech stocks.